The University of Rochester Medical Center is pleased to announce the addition of Eva Galka, M.D. as an Assistant Professor of Surgery. Dr. Galka earned two Bachelor of Science degrees, with highest honors, in Ceramic Engineering and Biomedical Engineering & Applied Sciences from Rutgers University College of Engineering in New Brunswick, New Jersey. She received her medical degree from Dartmouth Medical School in Hanover, New Hampshire.
From 2000 through 2007, Dr. Galka completed her internship and residency in general surgery, as well as a two-year fellowship in surgical research, at Pennsylvania State University/Hershey Medical Center in Pennsylvania.
Dr. Galka completed a Surgical Oncology Fellowship at the University of Chicago in Illinois. She is licensed to practice medicine in the states of New York and Illinois and is board certified by the American Board of Surgery.
Dr. Galka has been the recipient of numerous awards and grants including the John Waldhausen Fellowship Award for Research, the American Physiological Society Research Recognition Award for Outstanding Abstract Presentation, the American Society of Colon and Rectal Surgeons (ASCRS) Research Grant and the University of Chicago Breast Cancer SPORE Developmental Research Project Grant. She has authored a wide variety of publications and has given numerous presentations at national surgery meetings throughout the United States.
In addition to being a member of professional organizations including the Society of Surgical Oncology, American Society of Clinical Oncology, American College of Surgeons, Association of Academic Surgeons and American Association of Cancer Research, Dr. Galka has developed clinical trials such as "A Pilot Study of Chemoprevention of Green Tea (Polyphenon E) in Women with Ductal Carcinoma in Situ (DCIS)."
Dr. Galka's clinical interests include the management of hepato-pancreatico-biliary (pancreatic and hepatobiliary cancers) and gastrointestinal malignancies, melanoma and sarcoma. Her research interests include understanding the mechanisms of apoptosis (programmed cell death) and its relation to novel treatments for cancer.